nodes	percent_of_prediction	percent_of_DWPC	metapath
Amprenavir—CYP3A4—type 2 diabetes mellitus	0.159	1	CbGaD
Amprenavir—ABCC1—Glyburide—type 2 diabetes mellitus	0.028	0.045	CbGbCtD
Amprenavir—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.027	0.0433	CbGbCtD
Amprenavir—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0216	0.0346	CbGbCtD
Amprenavir—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0205	0.0329	CbGbCtD
Amprenavir—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0195	0.0313	CbGbCtD
Amprenavir—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0192	0.0309	CbGbCtD
Amprenavir—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0188	0.0302	CbGbCtD
Amprenavir—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0183	0.0293	CbGbCtD
Amprenavir—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.018	0.0289	CbGbCtD
Amprenavir—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0174	0.0279	CbGbCtD
Amprenavir—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0172	0.0276	CbGbCtD
Amprenavir—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0164	0.0263	CbGbCtD
Amprenavir—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0164	0.0263	CbGbCtD
Amprenavir—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.016	0.0257	CbGbCtD
Amprenavir—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0154	0.0247	CbGbCtD
Amprenavir—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0151	0.0242	CbGbCtD
Amprenavir—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0146	0.0234	CbGbCtD
Amprenavir—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0142	0.0228	CbGbCtD
Amprenavir—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0136	0.0218	CbGbCtD
Amprenavir—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0136	0.0218	CbGbCtD
Amprenavir—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0132	0.0212	CbGbCtD
Amprenavir—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0126	0.0202	CbGbCtD
Amprenavir—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0124	0.02	CbGbCtD
Amprenavir—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0123	0.0197	CbGbCtD
Amprenavir—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0121	0.0195	CbGbCtD
Amprenavir—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0115	0.0184	CbGbCtD
Amprenavir—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0111	0.0178	CbGbCtD
Amprenavir—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0109	0.0176	CbGbCtD
Amprenavir—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0103	0.0166	CbGbCtD
Amprenavir—CYP3A4—Glipizide—type 2 diabetes mellitus	0.01	0.0161	CbGbCtD
Amprenavir—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00988	0.0159	CbGbCtD
Amprenavir—CYP3A5—Losartan—type 2 diabetes mellitus	0.0095	0.0152	CbGbCtD
Amprenavir—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00943	0.0151	CbGbCtD
Amprenavir—CYP2C8—Losartan—type 2 diabetes mellitus	0.00913	0.0147	CbGbCtD
Amprenavir—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00907	0.0146	CbGbCtD
Amprenavir—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00904	0.0145	CbGbCtD
Amprenavir—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00875	0.014	CbGbCtD
Amprenavir—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00838	0.0134	CbGbCtD
Amprenavir—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00791	0.0127	CbGbCtD
Amprenavir—CYP2C19—Losartan—type 2 diabetes mellitus	0.00766	0.0123	CbGbCtD
Amprenavir—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00696	0.0112	CbGbCtD
Amprenavir—ABCB1—Glyburide—type 2 diabetes mellitus	0.00676	0.0109	CbGbCtD
Amprenavir—CYP2C9—Losartan—type 2 diabetes mellitus	0.00637	0.0102	CbGbCtD
Amprenavir—ABCB1—Losartan—type 2 diabetes mellitus	0.00618	0.00992	CbGbCtD
Amprenavir—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.006	0.00963	CbGbCtD
Amprenavir—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00575	0.00923	CbGbCtD
Amprenavir—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00575	0.00923	CbGbCtD
Amprenavir—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00544	0.00873	CbGbCtD
Amprenavir—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00405	0.0065	CbGbCtD
Amprenavir—CYP3A4—Losartan—type 2 diabetes mellitus	0.0037	0.00595	CbGbCtD
Amprenavir—Fosamprenavir—CYP3A4—type 2 diabetes mellitus	0.00149	0.5	CrCbGaD
Amprenavir—Darunavir—CYP3A4—type 2 diabetes mellitus	0.00149	0.5	CrCbGaD
Amprenavir—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.000238	0.00156	CcSEcCtD
Amprenavir—Fatigue—Sitagliptin—type 2 diabetes mellitus	0.000238	0.00156	CcSEcCtD
Amprenavir—Connective tissue disorder—Metformin—type 2 diabetes mellitus	0.000237	0.00156	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Losartan—type 2 diabetes mellitus	0.000237	0.00156	CcSEcCtD
Amprenavir—Tremor—Gliclazide—type 2 diabetes mellitus	0.000235	0.00155	CcSEcCtD
Amprenavir—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.000235	0.00154	CcSEcCtD
Amprenavir—Mental disorder—Valsartan—type 2 diabetes mellitus	0.000232	0.00153	CcSEcCtD
Amprenavir—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000232	0.00152	CcSEcCtD
Amprenavir—Malnutrition—Valsartan—type 2 diabetes mellitus	0.000231	0.00152	CcSEcCtD
Amprenavir—Angioedema—Gliclazide—type 2 diabetes mellitus	0.00023	0.00151	CcSEcCtD
Amprenavir—Mental disorder—Orlistat—type 2 diabetes mellitus	0.00023	0.00151	CcSEcCtD
Amprenavir—Malnutrition—Orlistat—type 2 diabetes mellitus	0.000228	0.0015	CcSEcCtD
Amprenavir—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000228	0.0015	CcSEcCtD
Amprenavir—Flatulence—Valsartan—type 2 diabetes mellitus	0.000227	0.00149	CcSEcCtD
Amprenavir—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000226	0.00149	CcSEcCtD
Amprenavir—Rash—Repaglinide—type 2 diabetes mellitus	0.000226	0.00149	CcSEcCtD
Amprenavir—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000226	0.00148	CcSEcCtD
Amprenavir—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000226	0.00148	CcSEcCtD
Amprenavir—Flatulence—Orlistat—type 2 diabetes mellitus	0.000225	0.00148	CcSEcCtD
Amprenavir—Headache—Repaglinide—type 2 diabetes mellitus	0.000225	0.00148	CcSEcCtD
Amprenavir—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.000224	0.00147	CcSEcCtD
Amprenavir—Cardiac disorder—Metformin—type 2 diabetes mellitus	0.000224	0.00147	CcSEcCtD
Amprenavir—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000224	0.00147	CcSEcCtD
Amprenavir—Connective tissue disorder—Irbesartan—type 2 diabetes mellitus	0.000224	0.00147	CcSEcCtD
Amprenavir—Abdominal discomfort—Ramipril—type 2 diabetes mellitus	0.00022	0.00145	CcSEcCtD
Amprenavir—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000219	0.00144	CcSEcCtD
Amprenavir—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000218	0.00143	CcSEcCtD
Amprenavir—Anorexia—Glyburide—type 2 diabetes mellitus	0.000218	0.00143	CcSEcCtD
Amprenavir—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000217	0.00143	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000216	0.00142	CcSEcCtD
Amprenavir—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000215	0.00142	CcSEcCtD
Amprenavir—Neutropenia—Ramipril—type 2 diabetes mellitus	0.000215	0.00141	CcSEcCtD
Amprenavir—Myalgia—Gliclazide—type 2 diabetes mellitus	0.000214	0.00141	CcSEcCtD
Amprenavir—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000214	0.0014	CcSEcCtD
Amprenavir—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000213	0.0014	CcSEcCtD
Amprenavir—Nausea—Repaglinide—type 2 diabetes mellitus	0.000213	0.0014	CcSEcCtD
Amprenavir—Asthenia—Glipizide—type 2 diabetes mellitus	0.000213	0.0014	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000212	0.0014	CcSEcCtD
Amprenavir—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000212	0.0014	CcSEcCtD
Amprenavir—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.000211	0.00139	CcSEcCtD
Amprenavir—Discomfort—Gliclazide—type 2 diabetes mellitus	0.000211	0.00139	CcSEcCtD
Amprenavir—Angioedema—Valsartan—type 2 diabetes mellitus	0.000211	0.00139	CcSEcCtD
Amprenavir—Malnutrition—Metformin—type 2 diabetes mellitus	0.00021	0.00138	CcSEcCtD
Amprenavir—Pruritus—Glipizide—type 2 diabetes mellitus	0.00021	0.00138	CcSEcCtD
Amprenavir—Angioedema—Orlistat—type 2 diabetes mellitus	0.000208	0.00137	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000208	0.00137	CcSEcCtD
Amprenavir—Flatulence—Metformin—type 2 diabetes mellitus	0.000207	0.00136	CcSEcCtD
Amprenavir—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000205	0.00135	CcSEcCtD
Amprenavir—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000204	0.00134	CcSEcCtD
Amprenavir—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000204	0.00134	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.000203	0.00133	CcSEcCtD
Amprenavir—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000203	0.00133	CcSEcCtD
Amprenavir—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000203	0.00133	CcSEcCtD
Amprenavir—Acute coronary syndrome—Ramipril—type 2 diabetes mellitus	0.000202	0.00133	CcSEcCtD
Amprenavir—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000201	0.00132	CcSEcCtD
Amprenavir—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000201	0.00132	CcSEcCtD
Amprenavir—Myocardial infarction—Ramipril—type 2 diabetes mellitus	0.000201	0.00132	CcSEcCtD
Amprenavir—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000199	0.00131	CcSEcCtD
Amprenavir—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000199	0.00131	CcSEcCtD
Amprenavir—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000198	0.0013	CcSEcCtD
Amprenavir—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000198	0.0013	CcSEcCtD
Amprenavir—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000198	0.0013	CcSEcCtD
Amprenavir—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000197	0.0013	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000197	0.0013	CcSEcCtD
Amprenavir—Tremor—Metformin—type 2 diabetes mellitus	0.000197	0.00129	CcSEcCtD
Amprenavir—Myalgia—Valsartan—type 2 diabetes mellitus	0.000196	0.00129	CcSEcCtD
Amprenavir—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000196	0.00129	CcSEcCtD
Amprenavir—Flatulence—Irbesartan—type 2 diabetes mellitus	0.000195	0.00128	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000195	0.00128	CcSEcCtD
Amprenavir—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000194	0.00128	CcSEcCtD
Amprenavir—Myalgia—Orlistat—type 2 diabetes mellitus	0.000194	0.00128	CcSEcCtD
Amprenavir—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000194	0.00127	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000193	0.00127	CcSEcCtD
Amprenavir—Discomfort—Orlistat—type 2 diabetes mellitus	0.000192	0.00126	CcSEcCtD
Amprenavir—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000189	0.00125	CcSEcCtD
Amprenavir—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000189	0.00124	CcSEcCtD
Amprenavir—Vomiting—Glipizide—type 2 diabetes mellitus	0.000189	0.00124	CcSEcCtD
Amprenavir—Rash—Glipizide—type 2 diabetes mellitus	0.000187	0.00123	CcSEcCtD
Amprenavir—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000187	0.00123	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000187	0.00123	CcSEcCtD
Amprenavir—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000187	0.00123	CcSEcCtD
Amprenavir—Headache—Glipizide—type 2 diabetes mellitus	0.000186	0.00122	CcSEcCtD
Amprenavir—Tremor—Irbesartan—type 2 diabetes mellitus	0.000186	0.00122	CcSEcCtD
Amprenavir—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000185	0.00121	CcSEcCtD
Amprenavir—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000184	0.00121	CcSEcCtD
Amprenavir—Flatulence—Losartan—type 2 diabetes mellitus	0.000184	0.00121	CcSEcCtD
Amprenavir—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000183	0.0012	CcSEcCtD
Amprenavir—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000183	0.0012	CcSEcCtD
Amprenavir—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000181	0.00119	CcSEcCtD
Amprenavir—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000181	0.00119	CcSEcCtD
Amprenavir—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000181	0.00119	CcSEcCtD
Amprenavir—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.00018	0.00119	CcSEcCtD
Amprenavir—Anorexia—Valsartan—type 2 diabetes mellitus	0.00018	0.00118	CcSEcCtD
Amprenavir—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000179	0.00118	CcSEcCtD
Amprenavir—Myalgia—Metformin—type 2 diabetes mellitus	0.000179	0.00118	CcSEcCtD
Amprenavir—Headache—Pioglitazone—type 2 diabetes mellitus	0.000178	0.00117	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000178	0.00117	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000177	0.00116	CcSEcCtD
Amprenavir—Discomfort—Metformin—type 2 diabetes mellitus	0.000177	0.00116	CcSEcCtD
Amprenavir—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000177	0.00116	CcSEcCtD
Amprenavir—Nausea—Glipizide—type 2 diabetes mellitus	0.000176	0.00116	CcSEcCtD
Amprenavir—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000176	0.00116	CcSEcCtD
Amprenavir—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000175	0.00115	CcSEcCtD
Amprenavir—Tremor—Losartan—type 2 diabetes mellitus	0.000175	0.00115	CcSEcCtD
Amprenavir—Rash—Glimepiride—type 2 diabetes mellitus	0.000175	0.00115	CcSEcCtD
Amprenavir—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000174	0.00115	CcSEcCtD
Amprenavir—Rash—Sitagliptin—type 2 diabetes mellitus	0.000174	0.00114	CcSEcCtD
Amprenavir—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000174	0.00114	CcSEcCtD
Amprenavir—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000174	0.00114	CcSEcCtD
Amprenavir—Headache—Glimepiride—type 2 diabetes mellitus	0.000173	0.00114	CcSEcCtD
Amprenavir—Headache—Sitagliptin—type 2 diabetes mellitus	0.000173	0.00114	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000172	0.00113	CcSEcCtD
Amprenavir—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000171	0.00112	CcSEcCtD
Amprenavir—Angioedema—Losartan—type 2 diabetes mellitus	0.000171	0.00112	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.00017	0.00111	CcSEcCtD
Amprenavir—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000169	0.00111	CcSEcCtD
Amprenavir—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000169	0.00111	CcSEcCtD
Amprenavir—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000168	0.00111	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000168	0.0011	CcSEcCtD
Amprenavir—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000168	0.0011	CcSEcCtD
Amprenavir—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000167	0.0011	CcSEcCtD
Amprenavir—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000167	0.0011	CcSEcCtD
Amprenavir—Skin disorder—Metformin—type 2 diabetes mellitus	0.000167	0.0011	CcSEcCtD
Amprenavir—Nausea—Glimepiride—type 2 diabetes mellitus	0.000164	0.00108	CcSEcCtD
Amprenavir—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000164	0.00108	CcSEcCtD
Amprenavir—Asthenia—Glyburide—type 2 diabetes mellitus	0.000164	0.00108	CcSEcCtD
Amprenavir—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000164	0.00108	CcSEcCtD
Amprenavir—Anorexia—Metformin—type 2 diabetes mellitus	0.000163	0.00107	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000163	0.00107	CcSEcCtD
Amprenavir—Fatigue—Valsartan—type 2 diabetes mellitus	0.000162	0.00107	CcSEcCtD
Amprenavir—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000162	0.00107	CcSEcCtD
Amprenavir—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000162	0.00106	CcSEcCtD
Amprenavir—Pruritus—Glyburide—type 2 diabetes mellitus	0.000162	0.00106	CcSEcCtD
Amprenavir—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000161	0.00106	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000161	0.00106	CcSEcCtD
Amprenavir—Fatigue—Orlistat—type 2 diabetes mellitus	0.00016	0.00105	CcSEcCtD
Amprenavir—Malnutrition—Ramipril—type 2 diabetes mellitus	0.00016	0.00105	CcSEcCtD
Amprenavir—Myalgia—Losartan—type 2 diabetes mellitus	0.000159	0.00104	CcSEcCtD
Amprenavir—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000159	0.00104	CcSEcCtD
Amprenavir—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000159	0.00104	CcSEcCtD
Amprenavir—Rash—Bromocriptine—type 2 diabetes mellitus	0.000157	0.00104	CcSEcCtD
Amprenavir—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000157	0.00103	CcSEcCtD
Amprenavir—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000157	0.00103	CcSEcCtD
Amprenavir—Discomfort—Losartan—type 2 diabetes mellitus	0.000157	0.00103	CcSEcCtD
Amprenavir—Headache—Bromocriptine—type 2 diabetes mellitus	0.000156	0.00103	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000156	0.00103	CcSEcCtD
Amprenavir—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000156	0.00103	CcSEcCtD
Amprenavir—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000154	0.00101	CcSEcCtD
Amprenavir—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000154	0.00101	CcSEcCtD
Amprenavir—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000154	0.00101	CcSEcCtD
Amprenavir—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000152	0.001	CcSEcCtD
Amprenavir—Tremor—Ramipril—type 2 diabetes mellitus	0.00015	0.000986	CcSEcCtD
Amprenavir—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000149	0.000982	CcSEcCtD
Amprenavir—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000149	0.00098	CcSEcCtD
Amprenavir—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000149	0.000979	CcSEcCtD
Amprenavir—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000148	0.000975	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000148	0.000973	CcSEcCtD
Amprenavir—Fatigue—Metformin—type 2 diabetes mellitus	0.000148	0.000972	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000147	0.000969	CcSEcCtD
Amprenavir—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000147	0.000967	CcSEcCtD
Amprenavir—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000147	0.000967	CcSEcCtD
Amprenavir—Angioedema—Ramipril—type 2 diabetes mellitus	0.000146	0.000961	CcSEcCtD
Amprenavir—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000145	0.000955	CcSEcCtD
Amprenavir—Anorexia—Losartan—type 2 diabetes mellitus	0.000145	0.000955	CcSEcCtD
Amprenavir—Vomiting—Glyburide—type 2 diabetes mellitus	0.000145	0.000954	CcSEcCtD
Amprenavir—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000145	0.000953	CcSEcCtD
Amprenavir—Rash—Glyburide—type 2 diabetes mellitus	0.000144	0.000946	CcSEcCtD
Amprenavir—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000144	0.000945	CcSEcCtD
Amprenavir—Headache—Glyburide—type 2 diabetes mellitus	0.000143	0.00094	CcSEcCtD
Amprenavir—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000141	0.000925	CcSEcCtD
Amprenavir—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00014	0.000922	CcSEcCtD
Amprenavir—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.00014	0.000922	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.00014	0.000919	CcSEcCtD
Amprenavir—Fatigue—Irbesartan—type 2 diabetes mellitus	0.00014	0.000917	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000139	0.000912	CcSEcCtD
Amprenavir—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000137	0.000899	CcSEcCtD
Amprenavir—Myalgia—Ramipril—type 2 diabetes mellitus	0.000136	0.000896	CcSEcCtD
Amprenavir—Nausea—Glyburide—type 2 diabetes mellitus	0.000136	0.000891	CcSEcCtD
Amprenavir—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000136	0.000891	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000135	0.00089	CcSEcCtD
Amprenavir—Asthenia—Valsartan—type 2 diabetes mellitus	0.000135	0.000888	CcSEcCtD
Amprenavir—Discomfort—Ramipril—type 2 diabetes mellitus	0.000135	0.000885	CcSEcCtD
Amprenavir—Asthenia—Orlistat—type 2 diabetes mellitus	0.000134	0.000878	CcSEcCtD
Amprenavir—Pruritus—Valsartan—type 2 diabetes mellitus	0.000133	0.000876	CcSEcCtD
Amprenavir—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000132	0.000871	CcSEcCtD
Amprenavir—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000132	0.00087	CcSEcCtD
Amprenavir—Pruritus—Orlistat—type 2 diabetes mellitus	0.000132	0.000866	CcSEcCtD
Amprenavir—Fatigue—Losartan—type 2 diabetes mellitus	0.000131	0.000863	CcSEcCtD
Amprenavir—Vomiting—Gliclazide—type 2 diabetes mellitus	0.00013	0.000857	CcSEcCtD
Amprenavir—Rash—Gliclazide—type 2 diabetes mellitus	0.000129	0.00085	CcSEcCtD
Amprenavir—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000129	0.000849	CcSEcCtD
Amprenavir—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000129	0.000847	CcSEcCtD
Amprenavir—Headache—Gliclazide—type 2 diabetes mellitus	0.000128	0.000844	CcSEcCtD
Amprenavir—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000128	0.000842	CcSEcCtD
Amprenavir—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000128	0.000841	CcSEcCtD
Amprenavir—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000127	0.000837	CcSEcCtD
Amprenavir—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000127	0.000834	CcSEcCtD
Amprenavir—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000125	0.000819	CcSEcCtD
Amprenavir—Anorexia—Ramipril—type 2 diabetes mellitus	0.000125	0.000818	CcSEcCtD
Amprenavir—Asthenia—Metformin—type 2 diabetes mellitus	0.000123	0.000809	CcSEcCtD
Amprenavir—Nausea—Gliclazide—type 2 diabetes mellitus	0.000122	0.000801	CcSEcCtD
Amprenavir—Pruritus—Metformin—type 2 diabetes mellitus	0.000121	0.000798	CcSEcCtD
Amprenavir—Abdominal pain—Losartan—type 2 diabetes mellitus	0.00012	0.000792	CcSEcCtD
Amprenavir—Vomiting—Valsartan—type 2 diabetes mellitus	0.00012	0.000787	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000119	0.000782	CcSEcCtD
Amprenavir—Rash—Valsartan—type 2 diabetes mellitus	0.000119	0.000781	CcSEcCtD
Amprenavir—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000119	0.00078	CcSEcCtD
Amprenavir—Vomiting—Orlistat—type 2 diabetes mellitus	0.000118	0.000778	CcSEcCtD
Amprenavir—Headache—Valsartan—type 2 diabetes mellitus	0.000118	0.000776	CcSEcCtD
Amprenavir—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000117	0.000771	CcSEcCtD
Amprenavir—Rash—Orlistat—type 2 diabetes mellitus	0.000117	0.000771	CcSEcCtD
Amprenavir—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000117	0.000771	CcSEcCtD
Amprenavir—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000117	0.000771	CcSEcCtD
Amprenavir—Headache—Orlistat—type 2 diabetes mellitus	0.000117	0.000766	CcSEcCtD
Amprenavir—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000116	0.000763	CcSEcCtD
Amprenavir—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000115	0.000753	CcSEcCtD
Amprenavir—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000114	0.000746	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000113	0.000741	CcSEcCtD
Amprenavir—Fatigue—Ramipril—type 2 diabetes mellitus	0.000113	0.00074	CcSEcCtD
Amprenavir—Nausea—Valsartan—type 2 diabetes mellitus	0.000112	0.000735	CcSEcCtD
Amprenavir—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000111	0.000728	CcSEcCtD
Amprenavir—Nausea—Orlistat—type 2 diabetes mellitus	0.000111	0.000727	CcSEcCtD
Amprenavir—Asthenia—Losartan—type 2 diabetes mellitus	0.000109	0.000718	CcSEcCtD
Amprenavir—Vomiting—Metformin—type 2 diabetes mellitus	0.000109	0.000717	CcSEcCtD
Amprenavir—Rash—Metformin—type 2 diabetes mellitus	0.000108	0.000711	CcSEcCtD
Amprenavir—Dermatitis—Metformin—type 2 diabetes mellitus	0.000108	0.00071	CcSEcCtD
Amprenavir—Pruritus—Losartan—type 2 diabetes mellitus	0.000108	0.000708	CcSEcCtD
Amprenavir—Headache—Metformin—type 2 diabetes mellitus	0.000107	0.000706	CcSEcCtD
Amprenavir—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000107	0.000702	CcSEcCtD
Amprenavir—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000104	0.000685	CcSEcCtD
Amprenavir—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000103	0.000679	CcSEcCtD
Amprenavir—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000103	0.000677	CcSEcCtD
Amprenavir—Rash—Irbesartan—type 2 diabetes mellitus	0.000102	0.000671	CcSEcCtD
Amprenavir—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000102	0.00067	CcSEcCtD
Amprenavir—Nausea—Metformin—type 2 diabetes mellitus	0.000102	0.00067	CcSEcCtD
Amprenavir—Headache—Irbesartan—type 2 diabetes mellitus	0.000101	0.000667	CcSEcCtD
Amprenavir—Vomiting—Losartan—type 2 diabetes mellitus	9.69e-05	0.000637	CcSEcCtD
Amprenavir—Nausea—Irbesartan—type 2 diabetes mellitus	9.61e-05	0.000632	CcSEcCtD
Amprenavir—Rash—Losartan—type 2 diabetes mellitus	9.6e-05	0.000631	CcSEcCtD
Amprenavir—Dermatitis—Losartan—type 2 diabetes mellitus	9.6e-05	0.000631	CcSEcCtD
Amprenavir—Headache—Losartan—type 2 diabetes mellitus	9.54e-05	0.000627	CcSEcCtD
Amprenavir—Asthenia—Ramipril—type 2 diabetes mellitus	9.37e-05	0.000616	CcSEcCtD
Amprenavir—Pruritus—Ramipril—type 2 diabetes mellitus	9.24e-05	0.000607	CcSEcCtD
Amprenavir—Nausea—Losartan—type 2 diabetes mellitus	9.05e-05	0.000595	CcSEcCtD
Amprenavir—Diarrhoea—Ramipril—type 2 diabetes mellitus	8.94e-05	0.000588	CcSEcCtD
Amprenavir—Vomiting—Ramipril—type 2 diabetes mellitus	8.3e-05	0.000546	CcSEcCtD
Amprenavir—Rash—Ramipril—type 2 diabetes mellitus	8.24e-05	0.000541	CcSEcCtD
Amprenavir—Dermatitis—Ramipril—type 2 diabetes mellitus	8.23e-05	0.000541	CcSEcCtD
Amprenavir—Headache—Ramipril—type 2 diabetes mellitus	8.18e-05	0.000538	CcSEcCtD
Amprenavir—Nausea—Ramipril—type 2 diabetes mellitus	7.76e-05	0.00051	CcSEcCtD
Amprenavir—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	5.88e-06	9.37e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	5.88e-06	9.37e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	5.87e-06	9.35e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—LPL—type 2 diabetes mellitus	5.86e-06	9.33e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	5.83e-06	9.29e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	5.82e-06	9.27e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	5.82e-06	9.27e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	5.81e-06	9.25e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	5.77e-06	9.19e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	5.74e-06	9.14e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	5.74e-06	9.14e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	5.74e-06	9.14e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—ADCY5—type 2 diabetes mellitus	5.73e-06	9.13e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	5.72e-06	9.12e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—GPX1—type 2 diabetes mellitus	5.71e-06	9.1e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.71e-06	9.09e-05	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—NOS3—type 2 diabetes mellitus	5.7e-06	9.08e-05	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PIK3R1—type 2 diabetes mellitus	5.7e-06	9.08e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	5.69e-06	9.07e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.69e-06	9.06e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	5.68e-06	9.05e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	5.65e-06	8.99e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	5.64e-06	8.98e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	5.64e-06	8.98e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	5.6e-06	8.92e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	5.6e-06	8.92e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	5.58e-06	8.89e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CD36—type 2 diabetes mellitus	5.56e-06	8.86e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	5.5e-06	8.77e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	5.5e-06	8.77e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PPP2CA—type 2 diabetes mellitus	5.49e-06	8.75e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	5.49e-06	8.74e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	5.49e-06	8.74e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	5.49e-06	8.74e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	5.49e-06	8.74e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	5.47e-06	8.71e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	5.45e-06	8.67e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.45e-06	8.67e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	5.44e-06	8.66e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	5.42e-06	8.64e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	5.42e-06	8.63e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	5.41e-06	8.62e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	5.41e-06	8.62e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	5.37e-06	8.55e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	5.36e-06	8.54e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	5.36e-06	8.54e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	5.35e-06	8.52e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	5.28e-06	8.4e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—MTHFR—type 2 diabetes mellitus	5.27e-06	8.4e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	5.26e-06	8.38e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	5.23e-06	8.33e-05	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PTGS2—type 2 diabetes mellitus	5.21e-06	8.3e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.2e-06	8.29e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	5.19e-06	8.27e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	5.19e-06	8.26e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	5.19e-06	8.26e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PPARA—type 2 diabetes mellitus	5.17e-06	8.24e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	5.15e-06	8.21e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	5.14e-06	8.19e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	5.14e-06	8.19e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	5.06e-06	8.05e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	5.05e-06	8.04e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—SRC—type 2 diabetes mellitus	5.04e-06	8.02e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—AGT—type 2 diabetes mellitus	5.01e-06	7.98e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	4.96e-06	7.9e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CALM1—type 2 diabetes mellitus	4.93e-06	7.84e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—APOE—type 2 diabetes mellitus	4.91e-06	7.82e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	4.9e-06	7.8e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.89e-06	7.79e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	4.86e-06	7.74e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.86e-06	7.74e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	4.85e-06	7.73e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—APOA1—type 2 diabetes mellitus	4.85e-06	7.73e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	4.84e-06	7.71e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	4.84e-06	7.7e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	4.81e-06	7.67e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	4.8e-06	7.64e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	4.77e-06	7.6e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	4.74e-06	7.56e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.74e-06	7.56e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	4.74e-06	7.55e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	4.72e-06	7.52e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	4.71e-06	7.5e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	4.66e-06	7.42e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	4.65e-06	7.41e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	4.63e-06	7.38e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.57e-06	7.27e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	4.52e-06	7.2e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	4.51e-06	7.18e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—TGFB1—type 2 diabetes mellitus	4.5e-06	7.17e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.47e-06	7.13e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.47e-06	7.13e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	4.47e-06	7.12e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.47e-06	7.12e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	4.46e-06	7.11e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	4.45e-06	7.09e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	4.43e-06	7.06e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.43e-06	7.06e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	4.42e-06	7.05e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—EGFR—type 2 diabetes mellitus	4.41e-06	7.03e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	4.41e-06	7.03e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	4.4e-06	7.01e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	4.39e-06	6.99e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.39e-06	6.99e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	4.38e-06	6.97e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.36e-06	6.94e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.36e-06	6.94e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.36e-06	6.94e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	4.35e-06	6.93e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.33e-06	6.9e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	4.33e-06	6.9e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	4.32e-06	6.88e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	4.32e-06	6.88e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	4.28e-06	6.81e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	4.26e-06	6.79e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.26e-06	6.78e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	4.24e-06	6.75e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	4.23e-06	6.73e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	4.23e-06	6.73e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	4.21e-06	6.71e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	4.21e-06	6.7e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	4.2e-06	6.7e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	4.19e-06	6.68e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	4.18e-06	6.66e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	4.17e-06	6.64e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	4.16e-06	6.62e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	4.15e-06	6.61e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	4.15e-06	6.6e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	4.11e-06	6.55e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	4.11e-06	6.54e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	4.1e-06	6.54e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	4.1e-06	6.53e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	4.07e-06	6.48e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	4.05e-06	6.45e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	4.03e-06	6.43e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	3.98e-06	6.35e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	3.98e-06	6.35e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	3.97e-06	6.32e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	3.95e-06	6.29e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	3.94e-06	6.27e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.91e-06	6.23e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.91e-06	6.23e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.91e-06	6.23e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	3.91e-06	6.23e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	3.89e-06	6.19e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	3.87e-06	6.16e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	3.84e-06	6.12e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.84e-06	6.11e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	3.83e-06	6.11e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	3.82e-06	6.08e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	3.81e-06	6.08e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.8e-06	6.06e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	3.79e-06	6.03e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	3.79e-06	6.03e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	3.76e-06	5.98e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.72e-06	5.93e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	3.72e-06	5.93e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	3.71e-06	5.91e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	3.69e-06	5.88e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	3.68e-06	5.86e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.68e-06	5.86e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	3.67e-06	5.84e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	3.66e-06	5.84e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	3.63e-06	5.79e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	3.63e-06	5.79e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	3.62e-06	5.77e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	3.62e-06	5.76e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	3.59e-06	5.73e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	3.59e-06	5.72e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	3.59e-06	5.72e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	3.58e-06	5.7e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.58e-06	5.7e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	3.56e-06	5.68e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	3.55e-06	5.65e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.54e-06	5.63e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.54e-06	5.63e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	3.48e-06	5.55e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	3.45e-06	5.5e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	3.42e-06	5.45e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	3.41e-06	5.43e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	3.39e-06	5.41e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—IL6—type 2 diabetes mellitus	3.39e-06	5.4e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.39e-06	5.4e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.39e-06	5.4e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	3.38e-06	5.39e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	3.37e-06	5.37e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	3.36e-06	5.36e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	3.34e-06	5.32e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	3.29e-06	5.24e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	3.25e-06	5.18e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	3.23e-06	5.15e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	3.17e-06	5.05e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	3.15e-06	5.02e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—AKT1—type 2 diabetes mellitus	3.13e-06	4.98e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	3.11e-06	4.96e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	3.11e-06	4.96e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—INS—type 2 diabetes mellitus	3.09e-06	4.93e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	2.97e-06	4.73e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	2.95e-06	4.69e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.92e-06	4.65e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.92e-06	4.65e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.91e-06	4.64e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.91e-06	4.63e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	2.9e-06	4.63e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	2.89e-06	4.6e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.87e-06	4.57e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	2.85e-06	4.53e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	2.84e-06	4.52e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.79e-06	4.44e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	2.78e-06	4.43e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	2.78e-06	4.43e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	2.71e-06	4.32e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.71e-06	4.32e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.71e-06	4.32e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.67e-06	4.26e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.66e-06	4.24e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	2.65e-06	4.22e-05	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—AKT1—type 2 diabetes mellitus	2.62e-06	4.17e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.6e-06	4.15e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.6e-06	4.13e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.56e-06	4.07e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	2.56e-06	4.07e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	2.54e-06	4.05e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	2.53e-06	4.04e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	2.53e-06	4.04e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.53e-06	4.03e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.5e-06	3.98e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	2.48e-06	3.95e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.4e-06	3.82e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.35e-06	3.74e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	2.34e-06	3.72e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	2.32e-06	3.69e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.28e-06	3.63e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.24e-06	3.56e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.23e-06	3.55e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.2e-06	3.51e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.94e-06	3.09e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.91e-06	3.03e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.75e-06	2.78e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	1.69e-06	2.69e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.67e-06	2.66e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.67e-06	2.66e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	1.65e-06	2.63e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.53e-06	2.43e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	1.43e-06	2.28e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	1.28e-06	2.03e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.25e-06	1.99e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.17e-06	1.87e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1.16e-06	1.85e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	7.68e-07	1.22e-05	CbGpPWpGaD
